Shares in Harvard Biosciences (NSDQ:HBIO) fell today after the medtech company met expectations on Wall Street with its third quarter earnings results, but dropped its guidance for the full year. The Holliston, Mass.-based company posted losses of $256,000, or 1¢ per share, on sales of $28.6 million for the three months ended September 30, seeing […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Philips launches all-in-one breast ultrasound system
Royal Philips (NYSE:PHG) said yesterday it launched an all-in-one breast assessment solution designed for use with its Epiq and Affiniti ultrasound systems. The newly launched solution, which has received CE Mark approval in the European Union and FDA 510(k) clearance in the US, is intended for the assessment, monitoring and treatment of breast diseases, the Amsterdam-based […]
Inovio touts intradermal delivery of HIV vaccine
Inovio Pharmaceuticals (NSDQ:INO) reported today that its synthetic HIV vaccine, Pennvax-GP, demonstrated durable antibody and T cell immune responses throughout a Phase I trial. The company found that Pennvax-GP plasmids delivered intradermally with Inovio’s Cellectra device triggered equivalent or superior immune responses in healthy volunteers compared to intramuscular delivery of the plasmids using the same device. […]
Pulse Biosciences registers for $45m rights offering
Pulse Biosciences (NSDQ:PLSE) yesterday filed for an upcoming rights offering targeted to its existing shareholders, looking to bring in approximately $45 million. Funds from the round will be used to support ongoing development of applications for the Hayward, Calif.-based company’s Nano-Pulse Stimulation technology. The Nano-Pulse Stimulation system is a novel, non-thermal tech platform designed to deliver nanosecond […]
Delcath registers $100m offering
Delcath Systems (NSDQ:DCTH) registered a $100 million offering with the SEC this week to support the development of its system designed to administer high-dose chemotherapy to the liver. The company’s product, melphalan hydrochloride for injection for use with the Delcath hepatic delivery system, won CE Mark clearance in Europe in 2012 and is under consideration by the FDA […]
Merit Medical logs Q3 sales and earnings beat
Merit Medical (NSDQ:MMSI) yesterday put up third-quarter numbers that beat expectations on both sales and earnings and confirmed that it’s on track to hit the midpoint of its guidance for the rest of the year. South Jordan, Utah-based Merit posted a swing to black ink for the three months ended Sept. 30, with profits of $16.6 […]
ResMed’s fiscal Q1 tops forecast
ResMed (NYSE:RMD) yesterday reported fiscal first-quarter results that beat the consensus forecast. The San Diego-based respiratory device maker posted profits of $105.7 million, or 73¢ per share, on sales of $588.3 million for the three months ended Sept. 30, for bottom-line growth of 22.8% on sales growth of 12.3% compared with fiscal Q1 2018. Adjusted to […]
Zimmer Biomet posts another sales & earnings beat
Zimmer Biomet (NYSE:ZBH) today posted third-quarter results that topped expectations for both sales and earnings and stood by its prior forecast for the rest of the year. The Warsaw, Ind.-based orthopedics giant reported profits of $162.2 million, or 79¢ per share, on sales of $1.84 billion for the three months ended Sept. 30, for a bottom-line […]
Stryker posts mixed bag Q3 earnings
Stryker (NYSE:SYK) today posted third quarter earnings that narrowly beat earnings per share expectations on Wall Street but missed revenue consensus, seeing its shares drop slightly in after-hours trading. The Kalamazoo, Mich.-based company posted profits of $590 million, or $1.55 per share, on sales of approximately $3.2 billion for the three months ended September 30, seeing […]
Researchers develop nanodevice to deliver immunotherapy
Researchers at Houston Methodist Research Institute have created a nanodevice that can be used to deliver immunotherapy to treat triple-negative breast cancer. The tiny device is designed to be inserted directly into a tumor, delivering a localized, sustained-release dose of therapy and eliminating the need for patients to undergo IV treatments. Get the full story […]
LeMaitre Vascular puts up $2m for BD’s Cardial
LeMaitre Vascular (NSDQ:LMAT) said today it inked a deal to acquire Becton Dickinson‘s (NYSE:BDX) Cardial subsidiary for approximately $2.3 million (EU €2 million). The Saint-Étienne, France-based subsidiary produces knitted and woven vascular grafts, valvulotomes and surgical glue, and reported approximately $3.3 million (EU €2.9 million) in sales over the past 12 months, Burlington, Mass.-based LeMaitre said. […]